PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs - 20 Cities, United States, 2015.

Abstract In the United States, 9% of human immunodeficiency virus (HIV) infections diagnosed in 2015 were attributed to injection drug use (1). In 2015, 79% of diagnoses of HIV infection among persons who inject drugs occurred in urban areas (2). To monitor the prevalence of HIV infection and associated behaviors among persons who inject drugs, CDC's National HIV Behavioral Surveillance (NHBS) conducts interviews and HIV testing in selected metropolitan statistical areas (MSAs) (3). The prevalence of HIV infection among persons who inject drugs in 20 MSAs in 2015 was 7%. In a behavioral analysis of HIV-negative persons who inject drugs, an estimated 27% receptively shared syringes and 67% had condomless vaginal sex in the previous 12 months. During the same period, 58% had tested for HIV infection and 52% received syringes from a syringe services program. Given the increased number of persons newly injecting drugs who are at risk for HIV infection because of the recent opioid epidemic (2,4), these findings underscore the importance of continuing and expanding health services, HIV prevention programs, and community-based strategies, such as those provided by syringe services programs, for this population.
PMID
Related Publications

Exchange Sex and HIV Infection Among Women Who Inject Drugs-20 US Cities, 2009.

HIV Risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection--National HIV Behavioral Surveillance System, 21 U.S. cities, 2010.

Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States.

HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.

HIV infection and HIV-associated behaviors among persons who inject drugs--20 cities, United States, 2012.

Authors

Mayor MeshTerms

Cities

Risk-Taking

Keywords
Journal Title mmwr. morbidity and mortality weekly report
Publication Year Start




PMID- 29324726
OWN - NLM
STAT- MEDLINE
DCOM- 20180112
LR  - 20180112
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 67
IP  - 1
DP  - 2018 Jan 12
TI  - HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs - 20
      Cities, United States, 2015.
PG  - 23-28
LID - 10.15585/mmwr.mm6701a5 [doi]
AB  - In the United States, 9% of human immunodeficiency virus (HIV) infections
      diagnosed in 2015 were attributed to injection drug use (1). In 2015, 79% of
      diagnoses of HIV infection among persons who inject drugs occurred in urban areas
      (2). To monitor the prevalence of HIV infection and associated behaviors among
      persons who inject drugs, CDC's National HIV Behavioral Surveillance (NHBS)
      conducts interviews and HIV testing in selected metropolitan statistical areas
      (MSAs) (3). The prevalence of HIV infection among persons who inject drugs in 20 
      MSAs in 2015 was 7%. In a behavioral analysis of HIV-negative persons who inject 
      drugs, an estimated 27% receptively shared syringes and 67% had condomless
      vaginal sex in the previous 12 months. During the same period, 58% had tested for
      HIV infection and 52% received syringes from a syringe services program. Given
      the increased number of persons newly injecting drugs who are at risk for HIV
      infection because of the recent opioid epidemic (2,4), these findings underscore 
      the importance of continuing and expanding health services, HIV prevention
      programs, and community-based strategies, such as those provided by syringe
      services programs, for this population.
FAU - Burnett, Janet C
AU  - Burnett JC
AD  - Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis,
      STD, and TB Prevention, CDC.
FAU - Broz, Dita
AU  - Broz D
AD  - Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis,
      STD, and TB Prevention, CDC.
FAU - Spiller, Michael W
AU  - Spiller MW
AD  - Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis,
      STD, and TB Prevention, CDC.
FAU - Wejnert, Cyprian
AU  - Wejnert C
AD  - Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis,
      STD, and TB Prevention, CDC.
FAU - Paz-Bailey, Gabriela
AU  - Paz-Bailey G
AD  - Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis,
      STD, and TB Prevention, CDC.
LA  - eng
PT  - Journal Article
DEP - 20180112
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - African Americans/psychology/statistics & numerical data
MH  - Behavioral Risk Factor Surveillance System
MH  - *Cities
MH  - European Continental Ancestry Group/psychology/statistics & numerical data
MH  - Female
MH  - HIV Infections/*epidemiology/ethnology
MH  - Hispanic Americans/psychology/statistics & numerical data
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Prevalence
MH  - *Risk-Taking
MH  - Socioeconomic Factors
MH  - Substance Abuse, Intravenous/*epidemiology/ethnology
MH  - United States/epidemiology
MH  - Young Adult
COIS- No conflicts of interest were reported.
EDAT- 2018/01/13 06:00
MHDA- 2018/01/13 06:01
CRDT- 2018/01/12 06:00
PHST- 2018/01/12 06:00 [entrez]
PHST- 2018/01/13 06:00 [pubmed]
PHST- 2018/01/13 06:01 [medline]
AID - 10.15585/mmwr.mm6701a5 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2018 Jan 12;67(1):23-28. doi: 10.15585/mmwr.mm6701a5.